tiprankstipranks
TipRanksTop Financial ExpertsInsidersTed Love

Ted Love Insider Profile

11 Followers
Ted Love, Director at Jazz Pharmaceuticals, holds 2.39K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 58.39K shares in Royalty Pharma (Ticker: RPRX), holds 5.48K shares in Gilead Sciences (Ticker: GILD).
See the Hottest Stocks Based on Insider Trading >
tipranks
Ted Love

Ted Love
Jazz Pharmaceuticals (JAZZ)
Director

Ranked #33,711 out of 108,921 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+53.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$10M
50.70%
35.73%
7.92%
5.64%
0.00% Others
A breakdown of Ted Love's holdings
See the Top Stocks by Insiders

Insider Roles

Oruka Therapeutics
(ORKA)
Director
Royalty Pharma
(RPRX)
Director
Gilead Sciences
(GILD)
Director
Jazz Pharmaceuticals
(JAZZ)
Director
+4 other positions
Roles that Ted Love holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Cascadian Therapeutics
(CASC)
Rating:Informative Buy
Date:Feb 03, 2017 - Feb 03, 2018
Return:+133.80%
The most profitable trade made by Ted Love
See the Latest Stocks Traded by Insiders

Ted Love's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
JAZZ
Jazz Pharmaceuticals
Sep 02, 2026
Director
Uninformative Sell
179.36K
$589.63K
GBT
Global Blood Therapeutics
Mar 03, 2021
―
Uninformative Buy
13.40K
$63.19M
PTLA
Portola Pharma
Jul 02, 2020
―
Uninformative Sell
280.35K
$0.00
RPRX
Royalty Pharma
Jun 08, 2026
Director
Uninformative Buy
―
$3.73M
SGEN
Seagen
Dec 15, 2023
―
Uninformative Sell
974.39K
$0.00
GPCR
Structure Therapeutics, Inc. Sponsored ADR
―
Director
―
―
GILD
Gilead Sciences
May 04, 2026
Director
Uninformative Buy
―
$828.06K
FOLD
Amicus
Jun 08, 2020
―
Uninformative Buy
―
$1.90M
CASC
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
HGENQ
Humanigen
―
―
―
$0.00
ONXX
Onyx Pharma
Feb 02, 2010
―
Uninformative Buy
―
―
ORKA
Oruka Therapeutics
―
Director
―
$5.30M
AFFY
Affymax
―
Director
―
―
BIO
Bio-Rad Laboratories
―
Director
―
$0.00
SNTS
Santarus
Jan 06, 2014
―
Uninformative Sell
10.74M
―
SVRA
Savara
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Ted Love's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Ted Love insider profile FAQ

What is the percentage of profitable transactions made by Ted Love?
The percentage of profitable transactions made by Ted Love is 50%.
    What is the average return per transaction made by Ted Love?
    The average return per transaction made by Ted Love is 53.50%.
      What stocks does Ted Love hold?
      Ted Love holds: JAZZ, GBT, PTLA, RPRX, SGEN, GPCR, GILD, FOLD, CASC, HGENQ, ONXX, ORKA, AFFY, BIO, SNTS, SVRA stocks.
        What was Ted Love’s latest transaction?
        Ted Love latest transaction was an Uninformative Sell of $179.36K.
          What was Ted Love's most profitable transaction?
          Ted Love’s most profitable transaction was an Informative Buy of CASC stock on February 3, 2017. The return on the trade was 133.80%.
            What is Ted Love's role in Jazz Pharmaceuticals?
            Ted Love's role in Jazz Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.